Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein

This publication has 82 references indexed in Scilit:

• Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events
  Circulation, 2003
• C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle
  Circulation, 2003
• hsCRP and HDL Effects of Statins Trial (CHEST): Rapid Effect of Statin Therapy on C-Reactive Protein and High-Density Lipoprotein Levels
  Heart Disease, 2003
• Do atherosclerosis and type 2 diabetes share a common inflammatory basis?
  European Heart Journal, 2002
• Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis
  Journal of the American College of Cardiology, 2000
• Seasonal Variations of Rheological and Hemostatic Parameters and Acute-Phase Reactants in Young, Healthy Subjects
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line
  International Journal of Immunopharmacology, 1996
• Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions
  Cytokine, 1994
• Detection and localization of tumor necrosis factor in human atheroma
  The American Journal of Cardiology, 1990
• Elevation of C-reactive protein in “active” coronary artery disease
  The American Journal of Cardiology, 1990